Spots Global Cancer Trial Database for HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Official Title: A Retrospective Chart Review of Real-world Treatment Outcomes in Patients With Locally Advanced Unresectable or Metastatic Urothelial Cancer Based on HER2 Expression
Study ID: NCT05902494
Conditions
Interventions
Study Description
Brief Summary: This study is being done to learn about urothelial cancers that make HER2 and how that affects treatment choices for participants with urothelial cancer. During this study, the medical and health records of participants will be reviewed to learn more about their health. Participants will have urothelial cancer that has grown in the body near where it started (locally advanced) and cannot be removed (unresectable) or has spread through the body (metastatic).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of California Irvine, Orange, California, United States
University of California San Francisco, San Francisco, California, United States
University of Colorado, Aurora, Colorado, United States
Avera, Sioux Falls, South Dakota, United States
Hospital Center University De Rouen, Rouen, , France
Contact Details
Name: Medical Monitor
Affiliation: Seagen Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
